SCHEMBL7308555

SCHEMBL7308555

COc1ccc2c([O])cccc2c1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MAPK1 P28482 1/20 0.46
MAOA P21397 1/20 0.44
MAPT P10636 5/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 4/20 0.39
CYP19A1 P11511 2/20 0.39
NQO2 P16083 2/20 0.39
LMNA P02545 2/20 0.39
POLB P06746 2/20 0.39
PABPC1 P11940 1/20 0.39
XBP1 P17861 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21830431 0.82 KDM4E (0.44) KDM4EALDH1A1SMN1; SMN2MAPK1MAOA
SCHEMBL17912823 0.82 ALDH1A1 (0.52) KDM4EALDH1A1SMN1; SMN2MAPK1MAOA
SCHEMBL8125448 0.81 MGAM (0.43) KDM4EALDH1A1SMN1; SMN2MAPK1MAPT
SCHEMBL1402324 0.79 IDO1 (0.47) KDM4EALDH1A1MAPK1MAOAMAPT
SCHEMBL16641096 0.79 ALDH1A1 (0.50) KDM4EALDH1A1SMN1; SMN2MAPK1MAOA
SCHEMBL1193759 0.78 CYP1A2 (0.52) KDM4EALDH1A1SMN1; SMN2MAPK1MAOA
SCHEMBL21830568 0.78 CYP19A1 (0.46) KDM4EALDH1A1SMN1; SMN2MAPK1MAOA
SCHEMBL1047908 0.77 SMN1; SMN2 (0.50) KDM4EALDH1A1SMN1; SMN2MAPK1MAPT
SCHEMBL911283 0.77 MAPT (0.50) KDM4EALDH1A1SMN1; SMN2MAPK1MAOA
SCHEMBL5254065 0.77 KDM4E (0.46) KDM4EALDH1A1SMN1; SMN2MAPK1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed